Portfolio Information

Complete List of Holdings as of April 30, 2020

Issuer Name Shareholding US $ Market Value % of Market Value
AIB GROUP PLC 418,951 573,887 1.31
AMRYT PHARMA EMA CVR RTS 300,819 0 0
AMRYT PHARMA FDA CVR RTS 300,819 0 0
AMRYT PHARMA PLC 300,819 388,352 0.89
AMRYT PHARMA REVENUE CVR RTS 300,819 0 0
APPLEGREEN PLC 251,921 866,856 1.98
BANK OF IRELAND GROUP 244,217 493,235 1.12
C&C GROUP PLC 385,471 946,721 2.16
CAIRN HOMES PLC 396,641 368,592 0.84
CIE DE SAINT-GOBAIN 45,756 1,213,936 2.77
COVANTA HOLDING CORP 73,043 568,275 1.3
CRH PLC 368,878 11,136,718 25.4
DALATA HOTEL GROUP PLC 276,534 900,032 2.05
DCC PLC 21,351 1,521,518 3.47
FLUTTER ENTERTAINMENT PLC 23,704 2,901,534 6.62
GLANBIA PLC 31,761 336,917 0.77
GLENVEAGH PROPERTIES PLC 1,126,099 702,169 1.6
GRAFTON GROUP PLC 216,007 1,727,577 3.94
GREENCOAT RENEWABLES PLC 440,825 545,880 1.24
GREENCORE GROUP PLC 179,092 410,980 0.94
IPL PLASTICS INC 180,354 583,062 1.33
IRISH CONTINENTAL GROUP PLC 177,922 668,770 1.53
KERRY GROUP PLC 7,017 805,102 1.84
KINGSPAN GROUP PLC 64,284 3,275,735 7.47
MALIN CORPORATION PLC 162,553 516,590 1.18
MINCON GROUP PLC 718,130 637,442 1.45
ORIGIN ENTERPRISES PLC 21,273 62,127 0.14
RYANAIR HOLDINGS PLC ADR 92,391 1,052,970 2.4
RYANAIR HOLDINGS PLC 22,757 1,444,387 3.29
SMURFIT KAPPA GROUP PLC 68,063 2,134,684 4.87
TOTAL PRODUCE PLC 748,397 885,745 2.02
UDG HEALTHCARE PLC 85,774 678,440 1.55
UNIPHAR PLC 1,740,000 2,764,841 6.31
VEOLIA ENVIRONNEME 50,924 1,087,366 2.48


The holdings are subject to change at any point in time hereafter.

Investment Objective: The New Ireland Fund, Inc. (NYSE: IRL), a closed-end non-diversified investment company, seeks long-term capital appreciation through investment of at least 80% of its assets in a portfolio of Irish securities.

The New Ireland Fund, Inc. is managed by KBI Global Investors (North America) Ltd, a wholly owned subsidiary of KBI Global Investors Ltd, and is listed on the New York Stock Exchange under the ticker symbol IRL. For further information, please contact the Fund at (800) 468-6475 or investor.query@newirelandfund.com Website: newirelandfund.com